-

Global Neurovascular Stent Market Report 2023: Continuous Enhancement of Stent Technology Bolsters Growth - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Neurovascular Stent Market Size, Share & Trends Analysis 2023-2029 MedCore Includes: Traditional Neurovascular Stents, Flow Diversion Stents, and 1 more" report has been added to ResearchAndMarkets.com's offering.

The global neurovascular stent market was valued at $555 million in 2022 and is expected to grow at a CAGR of 6.1% during the forecast period, reaching $840 million.

The full report suite on the global neurovascular stent market includes traditional neurovascular stents, flow diversion stents, and intrasaccular stents, reflecting the diversity of products available in the market.

MARKET REPORT DATA TYPES INCLUDED

  • Unit Sales, Average Selling Prices, Market Size & Growth Trends
  • COVID-19 Impact Analysis
  • Market Drivers & Limiters
  • Market Forecasts Until 2029, and Historical Data to 2019
  • Recent Mergers & Acquisitions
  • Company Profiles and Product Portfolios
  • Leading Competitors

GLOBAL NEUROVASCULAR STENT MARKET INSIGHTS

One of the primary drivers of the neurovascular stent market is the continuous enhancement of stent technology. These advancements make stent procedures quicker and safer, lowering patient risk and minimizing physician resistance to stenting products. However, some older-generation neurosurgeons who are not accustomed to using neurovascular stents may exhibit bias towards this relatively new technology in the interventional neuroradiology market.

GLOBAL NEUROVASCULAR STENT MARKET SHARE INSIGHTS

Within the global market for neurovascular stent, there are three key market players - Medtronic, MicroVention, Stryker. In 2022, Medtronic was the leader in the global neurovascular stent market. It currently offers the PipelineTFlex and the first-generation of the flow diverting stent.

MARKET SEGMENTATION SUMMARY

  • Global Traditional Stent Market
  • Global Flow Diversion Stent Market
  • Global Intrasaccular Stent Market

RESEARCH SCOPE SUMMARY

  • Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
  • Base Year: 2022
  • Forecast: 2023-2029
  • Historical Data: 2019-2022
  • Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
  • Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
  • Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, Internal Database.

Key Topics Covered:

  • Neurovascular Stent Market
  • Executive Summary
  • Global Neurovascular Stent Market Overview
  • Competitive Analysis
  • Markets Included
  • Regions Included
  • Introduction
  • Procedure Numbers
  • Total Neurovascular Stent Procedures
  • Market Overview
  • By Segment
  • By Region
  • Market Analysis and Forecast
  • Total Neurovascular Stent Market
  • Traditional Neurovascular Stent Market
  • Flow Diversion Stent Market
  • Intrasaccular Stent Market
  • Drivers and Limiters
  • Market Drivers
  • Market Limiters
  • Competitive Market Share Analysis

A selection of companies mentioned in this report includes

  • Medtronic
  • MicroVention
  • Stryker
  • Phenox
  • Balt
  • Cerenovus
  • Cerus Endovascular
  • Acandis
  • MicroPort

For more information about this report visit https://www.researchandmarkets.com/r/93pqdb

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Protein Engineering for Pharmaceutical Biotechnology Training Course: Understand How to Advance Therapeutic Development and Industrial Applications (Jan 21st - Jan 22nd, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Protein Engineering for Pharmaceutical Biotechnology Training Course (Jan 21st - Jan 22nd, 2026)" training has been added to ResearchAndMarkets.com's offering. Enhance your knowledge in protein engineering to understand how to advance therapeutic development and industrial applications. Protein-based therapeutics have significantly advanced and created new paradigms in disease treatment. Half of the top ten selling drugs in 2023 were protein-based therapeutics. Pro...

Development of Combination Products: 2 Day Critical Interactions Training Course (Feb 9th - Feb 10th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Development of Combination Products: Critical Interactions Training Course (Feb 9th - Feb 10th, 2026)" training has been added to ResearchAndMarkets.com's offering. The programme will cover the regulatory strategy to adopt and the relevant aspects of GMP and quality processes, including the data expectations for the CTD. It will also review the key relationships between quality, regulatory, R&D and production. Delegates will find this a comprehensive overview o...

Human Factors and Usability Engineering in the Development of Drug Delivery Products Training Course (Feb 11th - Feb 12th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Human Factors and Usability Engineering in the Development of Drug Delivery Products Training Course (Feb 11th - Feb 12th, 2026)" training has been added to ResearchAndMarkets.com's offering. This two-day workshop has been designed specifically for product developers who want to incorporate human factors testing into their product development or need to provide the regulators with specific usability data for their device to comply with the MDR. The format for the d...
Back to Newsroom